chr4-69639436-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001105677.2(UGT2A2):āc.205T>Cā(p.Phe69Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000682 in 1,613,148 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001105677.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UGT2A2 | NM_001105677.2 | c.205T>C | p.Phe69Leu | missense_variant | 1/6 | ENST00000604629.6 | |
UGT2A1 | NM_001252275.3 | c.716-3614T>C | intron_variant | ENST00000286604.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UGT2A2 | ENST00000604629.6 | c.205T>C | p.Phe69Leu | missense_variant | 1/6 | 1 | NM_001105677.2 | P1 | |
UGT2A1 | ENST00000286604.9 | c.716-3614T>C | intron_variant | 1 | NM_001252275.3 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000846 AC: 21AN: 248126Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134596
GnomAD4 exome AF: 0.0000602 AC: 88AN: 1461068Hom.: 1 Cov.: 31 AF XY: 0.0000660 AC XY: 48AN XY: 726774
GnomAD4 genome AF: 0.000145 AC: 22AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.205T>C (p.F69L) alteration is located in exon 1 (coding exon 1) of the UGT2A2 gene. This alteration results from a T to C substitution at nucleotide position 205, causing the phenylalanine (F) at amino acid position 69 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at